Inspire Medical Systems, Inc. (NYSE:INSP) Receives $211.91 Average Price Target from Analysts

Inspire Medical Systems, Inc. (NYSE:INSP - Get Free Report) has received an average rating of "Moderate Buy" from the eleven analysts that are presently covering the firm, Marketbeat Ratings reports. Three analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average 12 month price target among brokers that have covered the stock in the last year is $211.91.

A number of equities analysts recently issued reports on INSP shares. Wells Fargo & Company lowered their price objective on shares of Inspire Medical Systems from $195.00 to $174.00 and set an "equal weight" rating for the company in a research report on Tuesday, May 6th. Morgan Stanley decreased their target price on shares of Inspire Medical Systems from $220.00 to $200.00 and set an "overweight" rating on the stock in a research note on Tuesday, May 6th. Robert W. Baird increased their price target on Inspire Medical Systems from $230.00 to $236.00 and gave the company an "outperform" rating in a research note on Tuesday, May 6th. Stifel Nicolaus cut their price objective on Inspire Medical Systems from $190.00 to $175.00 and set a "hold" rating on the stock in a report on Monday, April 21st. Finally, Royal Bank of Canada lowered their target price on Inspire Medical Systems from $260.00 to $215.00 and set an "outperform" rating for the company in a report on Tuesday, April 15th.

Insider Activity

In other news, Director Shawn Mccormick sold 360 shares of the company's stock in a transaction on Friday, May 2nd. The shares were sold at an average price of $160.00, for a total value of $57,600.00. Following the sale, the director now directly owns 24,046 shares of the company's stock, valued at approximately $3,847,360. This represents a 1.48% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders own 4.10% of the company's stock.

Hedge Funds Weigh In On Inspire Medical Systems

A number of hedge funds have recently bought and sold shares of the company. Mutual of America Capital Management LLC grew its holdings in Inspire Medical Systems by 1.2% during the 4th quarter. Mutual of America Capital Management LLC now owns 4,540 shares of the company's stock worth $842,000 after acquiring an additional 55 shares during the period. True Wealth Design LLC boosted its position in shares of Inspire Medical Systems by 39.0% during the 4th quarter. True Wealth Design LLC now owns 196 shares of the company's stock valued at $36,000 after purchasing an additional 55 shares in the last quarter. Captrust Financial Advisors grew its stake in Inspire Medical Systems by 2.0% during the fourth quarter. Captrust Financial Advisors now owns 3,034 shares of the company's stock worth $562,000 after purchasing an additional 59 shares during the period. MML Investors Services LLC grew its stake in Inspire Medical Systems by 0.9% during the fourth quarter. MML Investors Services LLC now owns 7,941 shares of the company's stock worth $1,472,000 after purchasing an additional 67 shares during the period. Finally, Mariner LLC increased its holdings in Inspire Medical Systems by 1.6% in the fourth quarter. Mariner LLC now owns 4,837 shares of the company's stock worth $897,000 after purchasing an additional 77 shares in the last quarter. Institutional investors own 94.91% of the company's stock.

Inspire Medical Systems Stock Performance

Shares of INSP stock traded down $3.69 during trading on Monday, hitting $146.36. The company had a trading volume of 342,489 shares, compared to its average volume of 558,953. The firm has a market capitalization of $4.32 billion, a P/E ratio of 84.60, a price-to-earnings-growth ratio of 2.86 and a beta of 1.39. Inspire Medical Systems has a one year low of $123.00 and a one year high of $225.00. The stock's 50-day moving average price is $155.03 and its 200 day moving average price is $176.18.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last announced its quarterly earnings data on Monday, May 5th. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of ($0.23) by $0.33. Inspire Medical Systems had a return on equity of 8.19% and a net margin of 6.67%. The business had revenue of $201.32 million during the quarter, compared to the consensus estimate of $194.89 million. During the same period in the prior year, the company earned ($0.34) EPS. Inspire Medical Systems's revenue for the quarter was up 22.7% on a year-over-year basis. On average, research analysts anticipate that Inspire Medical Systems will post 2.16 earnings per share for the current fiscal year.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.